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This present study was designed to investigate the different effects of ginsenosides Rb1
and Rg1 on improving cognitive deficits in 4-month-old SAMP8 mice. Mice were divided
into six groups, including the SAMP8 group, the SAMP8 + Donepezil (1.6 mg/kg) group,
the SAMP8 + Rb1 (30 and 60 µmol/kg), and SAMP8 + Rg1 (30 and 60 µmol/kg) groups.
SAMR1 mice of the same age were used as the control group. Ginsenosides and
donepezil were administrated orally to animals for 8 weeks, then the learning and
memory ability of mice were measured by using Morris water maze (MWM) test, object
recognition test and passive avoidance experiments. The possible mechanisms were
studied including the anti-glial inflammation of Rb1 and Rg1 using HE staining,
immunohistochemistry and western blot experiments. Results revealed that Rb1 and
Rg1 treatment significantly improved the discrimination index of SAMP8 mice in the object
recognition test. Rb1 (60 µmol/kg) and Rg1 (30, 60 µmol/kg) could significantly shorten
the escape latency in the acquisition test of the MWM test in SAMP8 mice. Furthermore,
Rb1 and Rg1 treatments effectively reduced the number of errors in the passive avoidance
task in SAMP8 mice. Western blot experiments revealed that Rb1 showed higher effect
than Rg1 in decreasing protein expression levels of ASC, caspase-1 and Ab in the
hippocampus of SAMP8 mice, while Rg1 was more effective than Rb1 in decreasing the
protein levels of iNOS. In addition, although Rb1 and Rg1 treatments showed significant
protective effects in repairing neuronal cells loss and inhibiting the activation of astrocyte
and microglia in hippocampus of SAMP8 mice, Rb1 was more effective than Rg1. These
results suggest that Rb1 and Rg1 could improve the cognitive impairment in SAMP8mice,
and they have different mechanisms for the treatment of Alzheimer's disease.
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Alzheimer's disease (AD) is a neurodegenerative disease with
complex pathogenic factors. Its main symptoms are cognitive
impairment, execution disorder, memory impairment, obvious
mental disorder, sleep disorder, and even behavioral
abnormalities (Yang et al., 2017; Yutaro et al., 2018). Many
studies have indicated the cardinal features of Alzheimer
pathology are amyloid plaques, neurofibrillary tangles (NFTs),
associated with astrogliosis and microglial activation (Lane et al.,
2018; Boumenir et al., 2019). In recent years, increasing evidence
suggests that neuroinflammation is a causal role in the
pathogenesis of AD (Heneka et al., 2015; Zhang et al., 2015).
Apoptotic process closely associated with inflammasome, and
lead to neuronal cell death in AD (Xingxing and Tao, 2018).
Microglia and astrocyte are the main cells involved in
neuroinflammatory reactions. Activated microglia and
astrocyte can produce pro-inflammatory cytokines such as
tumor necrosis factor-a (TNF-a), interleukin-1b (IL-1b), and
interleukin-6 (IL-6) (Kima et al., 2019).
Ginsenosides are the main active components of Panax
ginseng C. A. Meyer, a traditional chinese herbal medicine,
which has a wide range of pharmacological effects, such as
anti-aging, anti-tumor, and nervous system protection, etc. In
recent years, researches have indicated that ginsenosides play a
pronounced positive role in the treatment of AD (Razgonova
et al., 2019) and have memory enhancement effects (Wang et al.,
2016). Ginsenosides Rg1 and Rb1 are the major ginsenosides in
ginseng with identified neuroprotective effects. Rg1 can
decreased Ab level, attenuated hippocampal histopathological
abnormalities and improved learning and memory in a rat model
of AD induced by injection of soluble beta-amyloid peptide 1–42
(Ab1–42) into the hippocampus (Quan et al., 2013). Rb1 reversed
memory impairment induced by aluminum (Al)—exposure,
probably through preventing tau hyperphosphorylation by
regulating p-GSK3 and PP2A level in the cortex and
hippocampus (Zhao et al., 2013). Our previous studies have
demonstrated that Rg1 and Rb1 intraperitoneal administration
to mice for 7 days were both effective in improving memory
deficiency induced by scopolamine, and Rg1 was more effective
than Rb1 in improving acquisition deficiency in the MWM test.
In addition, Rg1 can significantly reduce AChE activity than Rb1,
while Rb1 showed stronger effects than Rg1 in adjusting 5-HT
level in hippocampus in mice (Wang et al., 2010). These results
demonstrated that Rb1 and Rg1 have different neuroprotective
mechanisms. So in this study, we assessed the cognitive
enhancement effects of Rg1 and Rb1 in SAMP8 (senescence
accelerated mice P8) mice to make better understand of
their differences.MATERIALS AND METHODS
Animals
Sixty-six male SAMP8 mice (4-month-old) and 12 male
SAMR1 mice (4-month-old) were purchased from theFrontiers in Pharmacology | www.frontiersin.org 2Department of Experimental Animal Science, Peking
University Health Science Center (Qualified No. SCXK
2016-0010, Beijing, China). All animals were kept under a
controlled environment of 12-h light/dark (8:30 AM–8:30
PM) cycle at 23–25°C and a relative humidity of 50% ± 10%.
They had free access to food and water throughout the
experiment. All experimental procedures were performed
under the approval and supervision of the Care and Use of
Laboratory Animals of IMPLAD, CAMS & PUMC, China
(SLXD-20181225051), and in accordance with the National
Institute of Health Guide for the Care and Use of Laboratory
Animals. And all efforts were made to minimize the suffering
of the animals.
Chemicals and Reagents
Ginsenoside Rg1 and ginsenoside Rb1 (purity > 98%) were
purchased from Ruifensi Biological Technology Co., Ltd.
(Chengdu, China). Donepezil hydrochloride was purchased
from Eisai pharmaceutical Co., Ltd (Shanghai, China).
Experimental Design and Treatment
One month after breeding, SAMP8 mice were randomly assigned
to six groups as introduced in the abstract. The mice in SAMP8 +
Rb1, Rg1, or donepezil group were treated daily correspongding
drugs for 8 consecutive weeks before behavioral tests. The mice
in SAMR1 control group and the SAMP8 model group received
orally purified water during the experiment. Rb1, Rg1, and
donepezil were prepared with purified water and were
administered orally to mice at 0.1 ml/10g per day (Figure 1).
All behavioral experiments were conducted after 1 h of
drug administration.
Behavioral Experiments
Object Location Recognition (OLR) Test
The OLR test was used to evaluate the short-term and spatial
object recognition memory of mice (Ennaceur et al., 2009).
The procedure was divided into three stages: habituation,
familiarization, and test phases. In the habituation phase,
mice were allowed to explore the box (with no objects) for
10 min to acclimatize to the apparatus and reduce the animals'
fear of a new environment. The habituation phase was
repeated for three consecutive days. On the fourth day, the
familiarization and test phases bagan. Firstly, two identical
objects were fixed at the adjacent magnets in the chamber, and
mice were allowed to freely explore the box for 5 min. Then,
after an interval of 30 min, mice were returned to the box in
which one of the original objects changed location (“novel”)
and the other object remained in the original position
(“familiar”), and mice were allowed to freely explore the box
for 5 min again. Recognition memory was evaluated by the
following formula: DI = (TN - TF)/(TN + TF). DI
(discrimination index) refers to the difference between the
time exploring the novel and the familiar object, corrected for
total time exploring both objects. TN refers to the time spent
exploring the “novel” object, and TF refers to the time spent
exploring the “familiar” object (Lu et al., 2018a).June 2020 | Volume 11 | Article 834
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Twenty-four hours after the OLR test, the NOR test was carried
out, including the familiarization phase and the test phase, with
an interval of 30 min between two phases. The familiarization
phase performed similarly to the OLR test. In the test phase, mice
were returned to the box in which one of the original objects was
replaced by a new one (“novel”) and the other object remained
(“familiar”), and mice were allowed to freely explore the box for 5
min. Recognition memory was evaluated by the following
formula: DI = (TN − TF)/(TN + TF) corresponding to the
difference between the time exploring the novel and the familiar
object, corrected for total time exploring both objects (TN = time
spent exploring the “novel” object; TF= time spent exploring the
“familiar” object) (Lu et al., 2018b).
Open Field Test
The open field test used to assess the effects of Rb1 and Rg1 on
the locomotor activity for eliminating its interference in
cognitive function. The apparatus contain four identical boxes
(30 cm × 28 cm × 35 cm). After 30 min of drug administration,
each mouse was placed into the center of the box and allowed to
explore freely for 3 min. We recorded the total distances and
average speeding of the mice in 10 min. The floor of the box was
cleaned with 70% ethanol after each trial.
Morris Water Maze (MWM) Test
The water maze was consisted of a circular, black pool measuring
100 cm in diameter and 38 cm in height, filled with opaque water
(black ink) at the temperature of 23 ± 1°C, with a depth of 25 cm.
A submerged (1.5 cm beneath water surface) platform was fixed
in the pool (the target quadrant). Objects and staff were fixed as
the spatial reference to the mice during the experiment (Yang
et al., 2018). The MWM test composed of three sections
including the acquisition, the probe trail, and the reverse
memory tests.
Acquisition Phase (Learning)
In the acquisition test, mice were trained three times daily
during 6 consecutive days. Before each train, mice were placedFrontiers in Pharmacology | www.frontiersin.org 3on the hidden platform for 15 s to remember the location of
platform. Then, they were put in the pool and allowed to find
the platform for 90 s. If mice succeed to find the platform and
stay on it for 2 s, it was considered as a successful platform
search. If the mice failed to locate the hidden platform within
90 s, the mice were gently guided to the platform, and allowed
to stay there for 15 s. The escape latency, the swimming
distance, and average speed were recorded every day during
the test.
Probe Trial (Memory Consolidation)
Twenty-four hours after the acquisition test, the probe trail was
conducted to assess spatial reference memory of the animals, in
which the platform was removed. The mice were released from
the opposite quadrant of target quadrant. The numbers of target
crossing of mice within 90 s were recorded to reflect the retention
memory for the platform location.
Reverse Test (Reverse Memory)
In this section, the platform was moved to the opposite side of
the target quadrant to assess the animals' reverse memory
(Jinfeng et al., 2013). The process of this test was similar to the
acquisition test. The mice were allowed to find the hidden
platform in 90 s, and the escape latency to find the platform
was recorded. The test was last for 2 days.
Passive Avoidance Test
The step-through passive avoidance test box includes a dark
chamber and a light chamber with stainless steel grids. The mice
encountered an acquisition trail and a consolidation trail. In the
acquisition trial, after 3 min habitation, each mouse was put into
the test box from the light chamber and allowed to explore 5 min
in the test box. When the mouse entered the dark chamber, it will
suffer to 0.5 mA electric foot shock in dark chamber. Twenty-
four hours later, the consolidation trial was performed as before.
The latency and the error times to enter the dark chamber were
recorded in mice. This passive avoidance test was used to assess
the non-spatial memory in mice.FIGURE 1 | Timeline for the experimental procedure.June 2020 | Volume 11 | Article 834
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After all behavioral tests, mice were anesthetized and sacrificed.
The cortical and hippocampal regions were collected and deep
frozen in liquid nitrogen followed by transfer to −80°C for
further analysis.
Brain Immunohistochemistry
Three mice of each group were anesthetized with 5% chloral
hydrate and transcardially perfused with 0.9% saline followed by
4% paraformaldehyde. Brains were removed and post-fixed in the
same fixative solution for 24 h at 4°C. All immunohistochemistry
procedures were conducted according to the previously studies
(Aragão et al., 2018; Lamarão-Vieira et al., 2019). Paraffin-
embedded sections were dewaxed, hydrated, and rinsed. Then,
antigen recovery was performed with citrate buffer solution (pH
6.0), previously heated to 60°C for 23min. Sections were kept at
room temperature for 20min to decrease the temperature and
incubated in 3% hydrogen peroxide solution (H2O2) for 25min to
block endogenous peroxidase and then incubated with antibodies.
After that, sections were incubated with 3% bovine serum albumin
(BSA, Solarbio) for 30 min. Primary antibodies were against Iba-1
(Abcam, Ab178847) and GFAP (CST, 12389s). Sections were
rinsed three times (5 min/time) with 0.1M phosphate-buffered
saline (PBS, PH 7.4) and revealed with 3, 3-diaminobenzidine
(DAB). After DAB staining, sections were counterstained by
hematoxylin for 3 min, dehydrate through alcohol gradient and
xylene. The sections observed under microscope and the activated
cells counted from three different areas in each section.Statistical Analysis
All data were analyzed using the SPSS 21.0 software package
(IBM, USA) and represented as means ± standard error of the
mean (SEM). The data of the acquisition trials in MWM were
analyzed using the two-way repeated measures ANOVA, and
other data were analyzed by one-way ANOVA followed by
multiple post hoc comparisons using the least significant
difference (LSD) test. P value 0.05 was considered statistically
significant difference.Frontiers in Pharmacology | www.frontiersin.org 4RESULTS
Effects of Ginsenosides Rb1 and Rg1 on
the OLR Task in SAMP8 Mice
In the familiarization phase, Figure 2A showed that compared to
the SAMR1 mice, SAMP8 mice did not significant differences in
the total exploration time (p > 0.05). Treatment with Rb1 (30, 60
mmol/kg), Rg1 (30, 60 mmol/kg) and donepezil did not showed
significant changes in the total exploration time, which suggested
that there were no differences on the ability of exploration and
preference for location in mice. In the test phase, the DI of
SAMP8 mice significantly decreased (32.79%) compared with
the SAMR1 mice, whereas all treatment groups elevated the DI
significantly as compared to the SAMP8 group (p < 0.01, Figure
2B), indicating both Rb1 and Rg1 administrations could improve
the object location memory deficit in SAMP8 mice.
Effects of Ginsenosides Rb1 and Rg1 on
the NOR Task in SAMP8 Mice
As shown in Figure 3A, in the familiarization phase, mice in the
SAMR1, the SAMP8, the donepezil, the Rg1 and Rb1 treatment
groups displayed non-significant similar preference toward two
similar objects (p > 0.05). These results demonstrated that there
was no significant difference on the ability of exploration and
preference for object location in mice.
As indicated in Figure 3B, the DI of SAMP8 mice was 49.28%
significantly lower than those in the SAMR1 group (p < 0.01).
However, all treatment groups could significantly increase the DI
in SAMP8 mice (p < 0.01). It illustrated that the SAMP8 mice
treated with Rb1 or Rg1 could reverse the NOR memory deficit.
Effects of Ginsenosides Rb1 and Rg1 on
Locomotor Activity of SAMP8 Mice
As shown in Figure 4, there was no significant difference
between the SAMR1 and SAMP8 mice in the total distance
(p > 0.05) and the average speed (p > 0.05). Treatment with Rb1,
Rg1, or donepezil did not show significant difference in
locomotor activity (p > 0.05). Results indicated that cognitive
dysfunction did not affect locomotor activity in SAMP8 mice.A B
FIGURE 2 | Effects of ginsenosides Rb1 and Rg1 on short-term, spatial memory in object location recognition task. (A) Total exploration time in familiarization
phase; (B) Discrimination index in test phase. All data were expressed as means ± SEM (n = 10–12). ##p < 0.01versus the SAMR1 group; **p < 0.01versus the
SAMP8 group.June 2020 | Volume 11 | Article 834
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Spatial Learning and Memory Deficits in
the MWM Test in SAMP8 Mice
In the acquisition test, as shown in Figures 5A, B, there was no
significant difference in the average speed and total swimming
distance in the SAMR1, SAMP8, donepezil, Rg1 and Rb1 groups
from day 1 to day 6, except the average speed of the Rg1 30 mmol/kg
treatment group was higher than that of SAMP8 mice on day 2. In
Figure 5C, the escape latency in the acquisition test in SAMP8mice
was significantly longer than that of the SAMR1 mice from day 5
(44.65%) to day 6 (41.20%), illustrating spatial reference memory
impairment in SAMP8 mice (p < 0.05, p < 0.01). Rb1 (60 mmol/kg)
and Rg1 (30 mmol/kg) treatment could significantly shorten the
escape latency on day 6 (p < 0.05). In the probe trial (Figure 5D),
the number of target crossings of SAMP8 mice was 42.85% lower
than the SAMR1 mice (p < 0.05), while Rb1 or Rg1 treatment did
not show significantly effect in SAMP8 mice.
As shown in Figure 6, the escape latency of SAMP8 mice was
45.79% longer than that of the SAMR1 mice on day 2, illustrating
the ability of SAMP8 mice to relearn was affected (p < 0.05). Rg1
(30 mmol/kg) or donepezil treatment effectively decreased the
escape latency on day 2. These indicated that only Rg1 (30 mmol/
kg) could significantly improve the relearn ability dysfunction in
SAMP8 mice.Frontiers in Pharmacology | www.frontiersin.org 5Effects of Ginsenosides Rb1 and Rg1 on
Non-Spatial Memory Deficits in the
Passive Avoidance Test
In the acquisition phase, as shown in Figure 7A, the number of
errors in SAMP8 mice was 57.52% higher than the SAMR1 mice
(p < 0.05). The donepezil, Rb1 (30, 60 mmol/kg), or Rg1 (30, 60
mmol/kg) treatment could significantly reduce the number of
errors in SAMP8 mice (p < 0.05, p < 0.01).
In the test phase (Figure 7B), the latency into the dark
chamber of SAMP8 mice was 71.57% shorter than the SAMR1
mice (p < 0.01), while the donepezil, Rb1 (30 mmol/kg), or Rg1
(60 mmol/kg) treatment effectively extended the latency into the
dark chamber in SAMP8 mice. Furthermore, the number of
errors in SAMP8 group was more than twice of the SAMR1 mice
(p < 0.05, Figure 7C) and Rb1 (30 mmol/kg) treatment
significantly decreased the number of errors in SAMP8 mice
(p < 0.05).
Effects of Ginsenosides Rb1 and Rg1 on
TNF-a Levels in the Serum and the
Cerebral Cortex of SAMP8 Mice
As shown in Figure 8, the level of TNF-a in the serum of SAMP8
mice was 31.22% higher than of the SAMR1 mice (p < 0.05).
Treatment with Rb1 (30, 60 mmol/kg) or donepezil significantlyA B
FIGURE 4 | Effects of ginsenosides Rb1 and Rg1 on the locomotor activities in SAMP8 mice. (A) The total distance. (B) Average speed. All data were expressed as
means ± SEM (n = 8–12).A B
FIGURE 3 | Effects of ginsenosides Rb1 and Rg1 on short‐term, non-spatial memory in novel object recognition task. (A) Total exploration time in familiarization
phase; (B) Discrimination index in test phase. All data were expressed as means ± SEM (n = 10–11). ##p < 0.01 versus the SAMR1 group; **p < 0.01 versus the
SAMP8 group.June 2020 | Volume 11 | Article 834
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treatment SAMP8 mice (p < 0.01). However, treatments with
Rg1 (30, 60 mmol/kg) had no significant effects on TNF-a
production in SAMP8 mice, in spite of a tendency to a lower
accumulation of this cytokine. In addition, results showed TNF-
a concentration of Rb1 (60 mmol/kg) treatment group was lower
than that of Rg1 (60 mmol/kg) treatment group (p < 0.05).
In Figure 9, TNF-a concentration were significantly
decreased in the Rb1 (30, 60 mmol/kg) or donepezil treatment
groups as compared to the SAMP8 group in the cerebral cortex
of mice (p < 0.05). The SAMP8 group showed a tendency of
higher level of TNF-a than that of the SAMR1 group, but no
significant difference.Frontiers in Pharmacology | www.frontiersin.org 6Effects of Ginsenosides Rb1 and
Rg1 on Avoiding Neuronal Cells Loss in
SAMP8 Mice
Representative HE staining results in CA1 areas of the
hippocampus are shown in Figure 10. In SAMR1 mice,
neuronal cells were tightly packed and had large nuclei with
clear nucleoli in the hippocampus. In contrast, in SAMP8 group,
there were marked morphological changes: neurons were loosely
organized and uneven cytoplasm distribution in the
hippocampus. In Rg1 or Rb1 treatment group, neuronal cells
had large nuclei, and arranged in an orderly manner, indicating
that ginsenoside Rg1 or Rb1 treatment could reduce the loss of
neuronal cells.FIGURE 6 | Effects of ginsenosides Rb1 and Rg1 on the relearn ability of SAMP8 mice in the reverse test in MWM test. All data were expressed as the means ±
SEM (n = 8–11). #p < 0.05 versus the SAM1 group; *p < 0.05, **p < 0.01 versus the SAMP8 group.A B
C D
FIGURE 5 | Effects of ginsenosides Rb1 and Rg1 on the spatial learning and memory in the MWM test in SAMP8 mice. (A) Average speed. (B) Total swimming
distance. (C) The escape latency. (D) The number of target crossings. All data were expressed as means ± SEM (n = 8–11). #p < 0.05, ##p < 0.01versus the
SAMR1 group; *p < 0.05 versus the SAMP8 group.June 2020 | Volume 11 | Article 834
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Analysis of Microglias Activation
As shown in Figure 11A, the number of activated microglia
cells in the hippocampus of the SAMP8 mice was more than
twice of the SAMR1 mice (p < 0.01). Microglial cells were
brown after being labeled by Iba-1, and activated cells were
bigger and intensively stained. Donepezil, Rb1, or Rg1
treatment significantly decreased the number of activated
microglia cells in SAMP8 mice (Figure 11B). Compared
with the Rb1 treatment, Rg1 treatment showed lower effect
on the reduction of the activation of microglia cells in
SAMP8 mice.Frontiers in Pharmacology | www.frontiersin.org 7Analysis of Astrocytes Activation
Compared with the SAMR1 mice, the activated astrocytes in the
hippocampus of the SAMP8 mice were more than doubled (p <
0.01, Figure 12). GFAP positive expression cells proliferated
significantly, and these cells had larger nuclei and shorter
protrusions, and were darkly stained. In the SAMR1 mice,
astrocytes were mostly in a non-activated state. After treatment
with donepezil, Rb1, or Rg1, the number of activated astrocytes
in SAMP8 mice dramatically decreased. The number of activated
astrocytes in the Rb1 (30 mmol/kg) treatment group was
significantly lower than that of the Rg1 (30 mmol/kg) treatment
group (p < 0.05).FIGURE 8 | Effects of ginsenosides Rb1 and Rg1 on the TNF-a concentration in the serum of SAMP8 mice. All data were expressed as means ± SEM (n = 6–8).
#p < 0.05 versus the SAMR1 group; **p < 0.01 versus the SAMP8 group; &p < 0.05 versus the Rg1 (60 µmol/kg) group.A
B C
FIGURE 7 | Effects of ginsenosides Rb1 and Rg1 on non-spatial memory deficits in the passive avoidance test in SAMP8 mice. (A) The number of errors; (B) The
latency into the dark chamber; (C) The number of errors. All data were expressed as the means ± SEM (n = 8–10). #p < 0.05, ##p < 0.01 versus the SAMR1 group;
*p < 0.05, **p < 0.01 versus the SAMP8 group.June 2020 | Volume 11 | Article 834
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Inhibiting NLRP3 Inflammasome Assembly
NF-kB-mediated cell signaling is one of the common pathways
engaged in the inflammatory response. The expression of p-NF-
kB-p65 (p < 0.05), ASC (p <, 0.05), and caspase-1 (p < 0.05) in
the hippocampus of SAMP8 mice were twice level as that of
SAMR1 mice (p < 0.05). Rb1 (60 µmol/kg) treatment could
decrease the expression of ASC and caspase-1 in the
hippocampus of SAMP8 mice (Figure 13B, p < 0.05).
As shown in Figure 13A, the protein expression of iNOS in
SAMP8 mice was more than twice level as that of the SAMR1
mice (p < 0.05). Treatment with Rb1 (60 µmol/kg) or Rg1 (30, 60
µmol/kg) significant attenuated this increase in SAMP8 mice (p
< 0.05).
Effects of Ginsenosides Rb1 and Rg1 on
the Accumulation of Ab in Hippocampus
As shown in Figure 14, compared with the SAMR1 mice, the
protein level of Ab in the hippocampus of SAMP8 mice was
significantly increased three times higher than the former (p <
0.01). Rb1 (30, 60 µmol/kg) or Rg1 (60 µmol/kg) treatment
significantly reduced the expression of Ab in SAMP8 mice (p <
0.01), indicating Rb1 and the high dose of Rg1 could significantly
reduce the accumulation of Ab in SAMP8 mice. Besides, Rb1(30
µmol/kg) has a more prominent inhibitory effect on reducing the
protein level of Ab compared to the same dose of Rg1 (p < 0.05).DISCUSSION
Our study showed that ginsenosides Rb1 and Rg1 could
ameliorate memory impairments in SAMP8 mice and
suggested that their action may be mediated via modulation of
NLRP3 inflammasome, decreasing TNF-a level, astrocytes, and
microglias activation, ameliorating oxidative stress, and
inhibiting expression of p-NF-kB-p65, ASC, caspase-1,
and iNOS in hippocampus. Besides, amyloid b protein (Ab), a
major component of the senile plaque, is central to the
pathogenesis of AD. Treatments with Rb1 and Rg1
significantly reduced the production of Ab in the brain of
SAMP8 mice. In addition, our results showed for the first time
that Rb1 has stronger anti-inflammatory effects than Rg1 in
SAMP8 mice.
The SAMP8 is a classic accelerated aging model mouse (Gao
et al., 2019). It shows significant age-related impairment in
memory and learning ability (Akiguchi et al., 2017), and
demonstrated many pathological features similar to those of
AD patients such as altered amyloid b (Ab) proteins (Morley
et al., 2002), elevated phosphorylation of tau (Canudas et al.,
2005), as well as synaptic and dendritic pathological changes
(Nomura, 1999). In addition, SAMP8 mice show severe
inflammatory reactions and oxidative stress related to aging,
which can exacerbate neurological damage and cognitive decline
(Jiang et al., 2018; Puigoriol-Illamola et al., 2018). Moreover,
compared with same age of SAMR1 mice, SAMP8 mice show
significant emotional and memory impairments after six monthsFrontiers in Pharmacology | www.frontiersin.org 8of age (Shih-Yi et al., 2018). Previous studies exhibited that this
strain of mice accelerated aging from 4 months, showing learning
and memory disorders, and being in a low-stress and low-terror
dementia state with aging (Wang Miyamoto, 1997; Feng et al.,
2009). In our study, we found SAMP8 mice showed age-
associated behavioral impairments at 6 months, such as short-
term, long-term, spatial and non-spatial learning, and memory
deficits. These results are consistent with previous studies
(Miyamoto et al., 1986; Hosokawa et al., 1997). Furthermore,
SAMP8 mice at 6 months of age showed poor performance in
ORT test (Adler et al., 2014; Jin et al., 2016), and our treatment of
Rb1 and Rg1 effectively enhanced DI in both OLR and NOR
tests, which coincide with previous study on Rb1 and Rg1,
indicating their positvie effects on promote learning and
memory in normal animals or animals with cognitive
impairment (Qiong et al., 2014). However, our study for the
first time demonstrated that both Rb1 and Rg1 could
significantly ameliorate impaired short-term memory in
SAMP8 mice, and the two ginsenosides have similar
improvement effects.
MWM test was a classical behavioral method for evaluating
the reference, spatial, and working memory of rodents (Meiri
and Rosenblu, 1998; Yongliang et al., 2018; Ahmed et al., 2019).
It was reported that SAMP8 mice showed spatial memory
impairment from 6 months of age (Qin et al., 2008). The
results of the acquisition test suggest that the escape latency in
the SAMP8 group was significantly longer than the SAMR1
group from day 5 to day 6, and the number of target crossing
decreased in the probe trial. These results indicated that 6-
month-old SAMP8 mice showed significantly decreased
reference memory and long-term spatial memory, compared
with the SAMR1 mice. We used the reversal trial to evaluate
the reversal learning ability of mice, the reversal learning was
significantly damaged in 6-month-old SAMP8 mice, which are in
agreement with a previous study (Ding et al., 2019). Many
reports have confirmed that both Rb1 and Rg1 have
neuroprotective effects and can improve cognitive function in
AD animal models (Li et al., 2015; Lulin et al., 2017; Wang et al.,
2018). Our study demonstrated that Rb1 treatment significantly
ameliorated reference memory impairment in SAMP8 mice in
the acquisition trial task by shorting the escape latency, but Rg1
treatment showed effectively shortened the latency after training
to find the hidden platform. Zhang Juntian used a variety of
methods and models to observe the effects of ginseng on the
learning and memory in mice, demonstrating that ginsenoside
Rg1 can promote memory acquisition, consolidation and
reproduction, while Rb1 mainly improves memory acquisition
and reproduction (Zhang, 2000). This study showed that after
treatments with Rb1 and Rg1 for 8 weeks, Rb1 has a stronger
effect than Rg1 on improving the reference memory in SAMP8
mice. Although both Rb1 and Rg1 didn't significantly ameliorate
the spatial memory in the probe trial, in the reverse memory test,
we found Rg1 could significantly decrease the latency to reach a
hidden platform in SAMP8 mice.
The non-spatial memory improvement effect of Rg1 was
reported in previous researches, which found Rg1 improvedJune 2020 | Volume 11 | Article 834
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through test (Yu-Zhu Wang et al., 2009) and both Rg1 and Rb1
can improve the impaired memory performance induced by
SCOP in step-down passive avoidance test (Wang et al., 2010).
From the age of four months, SAMP8 mice showed the existence
of learning deficits in passive avoidance test (Lourdes et al., 2014;
Ren et al., 2018). In this study, the latency enter to the dark
chamber of SAMP8 mice was significantly shorter than the
SAMR1 mice, which showed for the first time that Rb1 has
stronger effects than Rg1 on improving non-spatial memory
deficits in SAMP8 mice in the passive avoidance test.
Growing body of evidence indicates that neuroinflammation
plays a key role in the prevalence and severity of AD, and its role
in the pathogenesis of AD is even greater than that of senile
plaques and nerve fiber entanglements (Heneka et al., 2015).
Astrocytes and microglias are the main non-neuronal cells that
mediate neuroinflammation (Stephenson et al., 2018). Microglias
are belong to the mononuclear phagocyte family and widely
considered to be the main immune effectors in the central
nervous system (Giulian, 1987). Astrocytes are key regulatorsFrontiers in Pharmacology | www.frontiersin.org 9of the brain's inflammatory response and reactive astrogliosis is a
universally acknowledged feature of AD (Frost and Li, 2017).
Activation of astrocytes and microglias result in the production
of major proinflammatory cytokines (TNF-a, IL-6, or IL-1b) and
neurotoxic factors (reactive oxidative species and tumor necrosis
factor-a), which are typically associated with neurodegenerative
diseases including AD (Lull and Block, 2010; Calabrese et al.,
2011a). Nuclear factor-kB (NF-kB) is a family of transcription
factors that have a crucial role in inflammation, survival, and
apoptosis. NF-kB has been shown to be activate by transcribing
the genes encoding pro-inflammatory cytokines, inducible nitric
oxide synthase (iNOS), cyclo-oxygenase-1, and cyclo-oxygenase-
2. All these induced a consequent increase in inflammation-
mediated signals (Calabrese et al., 2011b; Scuto et al., 2019). A
few studies have found that oxidative stress (Baltanás et al.,
2013), high levels of inflammation (Ren et al., 2018), activated
microglias and astrocytes (Chen et al., 2018) were found in brain
tissue of SAMP8 mice, especially the hippocampus. Rb1 and Rg1
were the active ingredients of the root of Panax ginseng C. A.
Mayer, which have anti-inflammatory and anti-oxidative stressFIGURE 9 | Effects of ginsenosides Rb1 and Rg1 on the TNF-a concentration in the cerebral cortex of SAMP8 mice. All data were expressed as means ± SEM (n =
6–8). *p < 0.05 versus the SAMP8 group; &p < 0.05 versus the Rg1 (60 µmol/kg) group.FIGURE 10 | Hematoxylin-eosin staining in the CA1 areas in the hippocampus of SAMP8 mice (×400). All data were expressed as means ± SEM (n = 3).June 2020 | Volume 11 | Article 834
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decrease the expression of ASC, caspase−1, caspase−5, IL−1b in
the hippocampus in mice injury induced by chronic
glucocorticoids exposure (Zhang et al., 2017). Interestingly, our
results showed that administration of Rb1 significantly inhibited
the production of TNF-a compared with the SAMP8 mice, while
Rg1 couldn't. In addition, our data indicated strong anti-
inflammatory activity of Rb1 and Rg1 on inhibiting activated
microglias and astrocytes in the hippocampus of SAMP8 mice,
and Rb1 has more stronger effects than Rg1. Rb1 is different from
Rg1 in chemical structure, Rb1 contains four sugars but Rg1 only
has two (Wang et al., 2010). Some reports on the neuroprotective
activity of these compounds implied their capacity to cross BBB,
but Rb1 and Rg1 showed low capacity to permeate towards the
brain. In the in vitro BBB model, ginsenoside Rb1 showed better
permeation than Rg1 (Fernández-Moriano et al., 2017). Rb1
mainly regulates stress and Rg1 mainly improves learning and
memory (Zhang, 2000). Therefore, in SAMP8 mice, Rb1 still
plays a major role in regulation of stress. Our study compared forFrontiers in Pharmacology | www.frontiersin.org 10the first time the effects of two ginsenosides on the improvement
of neuroinflammation in SAMP8 mice.
The inflammasome has been identified as a multi-protein
complex which plays a key role in innate immune responses
against pathogens and toxic metabolites (Nakanishi et al., 2018).
Among those types of inflammasomes, NOD-like receptor pyrin
domain containing 3 (NLRP3) possesses a critical role in
inflammatory response (Li et al., 2018), and associated with
many diseases, including AD, Parkinson's disease, diabetes,
atherosclerosis, and cerebral ischemia/reperfusion injuries
(Guo et al., 2016; Feng et al., 2018; Li et al., 2019; Nasonov
and Popkova, 2018; von Herrmann et al., 2018). NLRP3
activation induces aggregation of ASC, leading to caspase-1
activation, promoting the release of inflammatory factors
(Stancu et al., 2019). Furthermore, it was reported that Ab can
directly interacted with NLRP3, leading to the activation of the
NLRP3 inflammasome, resulting in the activation of caspase-1,
and microglial activation (Kayed et al., 2003; Halle et al., 2008).
In this study, we found that the expression of ASC and caspase-1A
B
FIGURE 11 | Effects of ginsenosides Rb1 and Rg1 on microglias in the hippocampus of SAMP8 mice. (A) Immunohistochemical staining of Iba-1 in the
hippocampus of mice brain (×400). (B) The number of Iba-1 positive cells. All data were expressed as means ± SEM (n = 3). ##p < 0.01 versus the SAMR1 group;
**p < 0.01 versus the SAMP8 group; &p < 0.05 versus the Rg1 (30 µmol/kg) group.June 2020 | Volume 11 | Article 834
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these are consistent with the findings of Jing Jiang (Jiang et al.,
2018) and Ning Ding (Ning et al., 2017). The iNOS in the central
nervous system is pathologic and plays an important role in
neuroinflammation (Kim et al., 2018). Increasing iNOS
expression was found in cultured astrocytes by Ab, and it
could result in excessive production of NO, causing neuronal
damage and death (Wang et al., 2017). In our results, the protein
level of iNOS in the hippocampus of Rb1 and Rg1 treatment
mice were lower than that of the SAMP8 mice, which suggest
Rb1 and Rg1 could inhibit the neuroinflammation in SAMP8
mice. The accumulations of Ab were found in AD animal
models, such as aging mice (Li et al., 2016), transgenic mice
with AD (Dionıśio et al., 2015), and over-expression of Ab is
often one of the important factors that promote chronicFrontiers in Pharmacology | www.frontiersin.org 11inflammation and oxidative stress in the brain (Batarseh et al.,
2016). Our results showed the significant increase of Ab
expression in the hippocampus of SAMP8 mice, indicating the
neuroinflammation associated with overexpression of Ab. We
found Rb1 and Rg1 treatment could decrease the overexpression
of Ab. Previous researches demonstrated that Rg1 may involve in
the activation of Akt/ERK 1/2 and PKA/CREA signaling
pathways, and the signal-regulated NF-kB/NO signaling
pathways, enhance neurite outgrowth and protect against Ab
induced damage (Huang et al., 2016; Wu et al., 2016; Hejian
et al., 2019). Rb1 could improve cognitive and memory functions
by inhibiting the levels of pro-apoptosis mediators and
improving the levels of anti-apoptosis mediators in the rat
model of AD induced by Ab 1-40 (Wang et al., 2018). In
addition, Rb1 showed a significant effect in reducing caspase-1A
B
FIGURE 12 | Effects of ginsenosides Rb1 and Rg1 on astrocytes in the hippocampus of SAMP8 mice. (A) Immunohistochemical staining of GFAP in the
hippocampus of mice brain (×400). (B) The number of GFAP positive cells. All data were expressed as means ± SEM (n = 3). ##p < 0.01 versus the SAMR1 group;
**p < 0.01 versus the SAMP8 group; &p < 0.05 versus the Rg1 (30 µmol/kg) group.June 2020 | Volume 11 | Article 834
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FIGURE 13 | Effects of ginsenosides Rb1 and Rg1 on the protein levels of p-NF-kB-p65, ASC, caspase-1, iNOS in the hippocampus of SAMP8 mice. (A) Protein
expression and gray intensity analysis of p-NF-kB-p65 and iNOS; (B) Protein expression and gray intensity analysis of ASC and caspase-1. All data were expressed
as means ± SEM (n = 3). #p < 0.05 versus the SAMR1 group; *p < 0.05 versus the SAMP8 group.FIGURE 14 | Effects of ginsenosides Rb1 and Rg1 on the protein level of Ab in the hippocampus of SAMP8 mice. All data were expressed as means ± SEM (n =
3). ##p < 0.01 versus the SAMR1 group; *p < 0.05 versus the SAMP8 group; &p < 0.05 versus the Rg1 (30 µmol/kg) group.Frontiers in Pharmacology | www.frontiersin.org June 2020 | Volume 11 | Article 83412
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inflammatory reaction in the brain by inhibiting ASC and
caspase-1.
In summary, although there are several studies have reported
that Rg1 and Rb1 are both effective in improving memory
impairment of AD animal models, especially in SAMP8 mice,
there was no report regarding the different protective effects of
Rg1 and Rb1 in facilitating neuroinflammation of SAMP8 mice
at the same dosage level. Our present study demonstrated that:
(1) Rb1 and Rg1 have similarly effects on improving the short-
term, spatial and non-spatial memory in SAMP8 mice. (2) Rg1
was more effective than Rb1 in improving escape acquisition and
reverse memory deficiency in SAMP8 mice. (3) For the first time,
we found that Rb1 has stronger effects than Rg1 on improving
non-spatial memory in SAMP8 mice. (4) Rb1 showed stronger
effects than the same dose of Rg1 in inhibiting glial cell
activation, the accumulation of Ab and NLRP3 inflammasome
relative protein in the hippocampus of SAMP8 mice. (5) Rg1 was
more effective than Rb1 in inhibiting the expression of iNOS in
the brain of SAMP8 mice. These results indicated that Rb1 might
be more potent than Rg1 on improving the acquisition impairment
and has stronger effect in inhibit neuroinflammation. However,
further study needed to do in order to make better explanation the
difference of Rg1 and Rb1 in cognitive enhancement.DATA AVAILABILITY STATEMENT
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Fernández-Moriano, C., González-Burgos, E., Iglesias, I., Lozano, R., and Gómez-
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